Alkano Thyroid Powder Recall: Inconsistent Active Ingredients
Alkano Chemicals recalls thyroid powder due to inconsistent levothyroxine and liothyronine levels. Affected products were sold in 25kg fiber drums with specific NDC and lot numbers.
Lower-risk recall
CGMP Deviations: Recall notice received from supplier that Thyroid Powder has inconsistent levels of the active ingredients levothyroxine and liothyronine.
Contact the company
What happened, in plain English
Alkano Chemicals is recalling thyroid powder products that may have inconsistent levels of active ingredients. This could lead to improper medication dosing if used without proper medical supervision. Read more at govinfonow.com/recall/39670-alkano-thyroid-powder-recall-inconsistent-active-ingredients.
Source Summary by GovInfoNow · govinfonow.com/recall/39670-alkano-thyroid-powder-recall-inconsistent-active-ingredients · Updated October 6, 2026 · FDA enforcement record: FDA #D-0008-2019
Cite this page
“Alkano Thyroid Powder Recall: Inconsistent Active Ingredients.” GovInfoNow, updated October 6, 2026. https://govinfonow.com/recall/39670-alkano-thyroid-powder-recall-inconsistent-active-ingredients. Based on FDA recall #D-0008-2019 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-0008-2019%22&limit=1).
Why it’s dangerous
The thyroid powder may have inconsistent levels of levothyroxine and liothyronine, which are active ingredients. This inconsistency could lead to improper medication dosing if used without proper medical supervision.
Who’s affected
People using thyroid powder for medical treatment in the US. Those with specific NDC 7807-0170-11 and lot #17050:01 are most at risk.
How to tell if you have this one
Check for NDC 7807-0170-11 and lot number 170501 on the product packaging. Products were sold in 25kg fiber drums with 5x1kg foil bags inside.
- Brand
Alkano Chemicals- Category
Drug
What to do — step by step
Check Product Details
Look for NDC 7807-0170-11 and lot number 170501 on the packaging.
Where it went and when
Where it was distributed
Distributed in Minnesota.
FDA distribution: “Distributed to two compounding firms in Minnesota.” States read from FDA’s own wording; “not listed” means the notice does not name it.
States: Minnesota.
Recall timeline
FDA terminated this recall 6 months after the firm started it.
- Firm started the recall
- FDA classified it Class II
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Questions people ask
Is this product dangerous?
The recall is due to inconsistent active ingredient levels, which could affect medication dosing. However, the risk is low and does not cause immediate harm.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-0008-2019 (August 30, 2018) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-0008-2019 to see it in context.
- Plain-language summary written by qwen3:4b on October 6, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.